About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Genomic Analysis of Evolution of Epithelia Ovarian Tumors

NCT03742388·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lei Li, M.D.
CONTACT
13911988831 lileigh@163.com

Lead

Lei Li

Age

Any age

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Confirmed primary epithelial ovarian borderline tumor with cancer
Signed an approved informed consents
Feasible for sampling

The record

StatusUnknown

PhaseNo phase

Taking part40

StartedNov 2018

UpdatedNov 15, 2018

Conditions

Epithelial Ovarian Cancer Epithelial Ovarian Tumor of Borderline Malignancy Driving Mutations Progression-free Survival

Where1

Lei Li
Beijing, Beijing Municipality, China

Clareo Health | A Genomic Analysis of Evolution of Epithelia Ovarian Tumors